| Name | Title | Contact Details |
|---|
Implant Vision is a Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Space Maintainers is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glissandra Skincare Inc. is committed to providing effective anti-aging skincare through its holistic approach to skin health. Glissandra products are available through its dedicated team of independent distributors, using network marketing (also known as multi-level marketing, MLM, or direct sales). Glissandra’s compensation plan offers one of the most generous payouts in the industry. Glissandra’s comprehensive skincare system is the result of almost 20 years of research and development at the Hong Kong University of Science and Technology, led by Professor Robert Ko. Over 100 research papers have been published on Glissandra’s key proprietary ingredient, Glissandrin, a suite of natural compounds extracted from the Schisandra berry. In-vivo and in-vitro studies have proven the ability of Glissandrin to address mitochondrial decay, the leading cause of aging, and to enhance the cell’s natural ability to fight oxidative damage.
Hillcrest Health Services offers the region’s largest continuum of health services for aging adults, including independent and assisted living, in-patient and outpatient rehabilitation, long-term care, memory support, adult day services, certified skilled home health and private duty home care, palliative care, telehealth services, and hospice care.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla`s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla`s research and development focuses on developing innovative products and drug delivery systems.